Results 31 to 40 of about 10,944,767 (389)

Genetic and Molecular Factors in Drug-Induced Liver Injury: A Review [PDF]

open access: yes, 2007
The diagnosis of drug-induced liver injury (DILI) is challenging and based on complex diagnostic criteria. DILI falls into two main categories i) intrinsic 'dose-dependent' Type A reactions ii) 'idiosyncratic' or Type B reactions (which are usually not ...
Andrade, RJ   +6 more
core   +3 more sources

Drug‐induced phospholipidosis

open access: yesFEBS Letters, 2006
Drug‐induced phospholipidosis is characterized by intracellular accumulation of phospholipids with lamellar bodies, most likely from an impaired phospholipid metabolism of the lysosome. Organs affected by phospholipidosis exhibit inflammatory reactions and histopathological changes.
Nora Anderson, Jürgen Borlak
openaire   +3 more sources

Severe drug-induced liver injury associated with prolonged use of Linezolid [PDF]

open access: yes, 2010
This study aims to describe a patient developing concomitant severe liver failure and lactic acidosis after long-term treatment with linezolid. A 55-year-old Caucasian woman developed concomitant severe liver failure and lactic acidosis after a treatment
Benoit, Dominique   +7 more
core   +1 more source

Corneal arcus and xanthomas in homozygous familial hypercholesterolemia: First report from China

open access: yesIndian Journal of Ophthalmology, 2013
We report the case of a 12-year-old male who developed corneal arcus and multiple skin lesions with a 10-year history of xanthomas. The lesions appeared over his fingers, hands, elbows, knees, buttocks and feet.
Xin Meng   +5 more
doaj   +1 more source

A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury [PDF]

open access: yes, 2019
BACKGROUND & AIMS: We performed genetic analyses of a multiethnic cohort of patients with idiosyncratic drug-induced liver injury (DILI) to identify variants associated with susceptibility.
Cirulli, Elizabeth T.   +4 more
core   +1 more source

Caenorhabditis elegans as a model system for studying drug induced mitochondrial toxicity [PDF]

open access: yes, 2015
Today HIV-1 infection is recognized as a chronic disease with obligatory lifelong treatment to keep viral titers below detectable levels. The continuous intake of antiretroviral drugs however, leads to severe and even life-threatening side effects ...
Brul, Stanley   +5 more
core   +8 more sources

Trimetazidine-Induced Parkinsonism: A Systematic Review

open access: yesFrontiers in Neurology, 2020
Importance: Trimetazidine (TMZ) is a medication given to patients with stable coronary artery disease. While it is reportedly well-tolerated, there are increasing numbers of reports of adverse events such as parkinsonism.Objectives: The purpose of this ...
Anna Marielle B. Dy   +5 more
doaj   +1 more source

Pityriasis rubra pilaris-like eruption following insulin therapy initiation

open access: yesDermatology Practical & Conceptual, 2016
Pityriasis rubra pilaris (PRP) is a chronic disorder of keratinization of unclear pathogenesis. PRP-like eruptions induced by drugs have rarely been described.
Talel Badri   +5 more
doaj   +1 more source

Drug-Induced Steatohepatitis [PDF]

open access: yesClinics in Liver Disease, 2013
Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease in the United States. The term NALFD was first used by Ludwig in 1980 to describe the presence of hepatic steatosis and steatohepatitis in a series of patients with no identifiable cause.
Vaishali Patel, Arun J. Sanyal
openaire   +3 more sources

Systemic Lupus Erythematosus in a Patient with Ulcerative Colitis: Co-Existing or Drug-Induced?

open access: yesJournal of Clinical Rheumatology and Immunology, 2019
We report a 49-year-old lady with ulcerative colitis (UC) who subsequently developed systemic lupus erythematosus (SLE) ten years later. By reviewing the drug history and serum autoimmune panel, we hypothesize that systemic lupus erythematosus may occur ...
Frances Feisi Sun   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy